✦ LIBER ✦

Granulocyte colony-stimulating factor supportive treatment following intensive chemotherapy in acute lymphocytic leukemia in first remission

✍ Scribed by Hagop M. Kantarjian; Elihu Estey; Susan O'Brien; Elias Anaissie; Miloslav Beran; Sherry Pierce; Lester Robertson; Michael J. Keating

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 503 KB
Volume: 72
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19931115)72:10<2950::aid-cncr2820721015>3.0.co;2-b

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Granulocyte-macrophage colony-stimulatin

Granulocyte-macrophage colony-stimulating factor support in therapy of high-risk acute lymphoblastic leukemia in children

✍ Saarinen-Pihkala, Ulla M.; Lanning, Marjatta; Perkki�, Mikko; M�kipernaa, Anne; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 2 views

## Background: Our purpose was to increase the dose intensity of chemotherapy and reduce the days with neutropenic fever in childhood high-risk (hr) acute lymphoblastic leukemia (all) by systematic use of granulocyte-macrophage colony-stimulating factor (gm-csf). ## Procedure: All children with h

Treatment of de novo acute myelogenous l

Treatment of de novo acute myelogenous leukemia with recombinant granulocyte macrophage-colony-stimulating factor in combination with standard induction chemotherapy: Effect of granulocyte macrophage-colony-stimulating factor on white blood cell counts

✍ Valent, Peter ;Sillaber, Christian ;Geissler, Klaus ;Andreeff, Michael ;Tafuri, 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 418 KB

GM-CSF is a major regulator of myelopoiesis. Recombinant human GM-CSF (250 micrograms/m2 per day i.v.) was used prior to chemotherapy ("3 + 7" scheme) to recruit leukemic blasts in vivo (de novo AML patients, n = 20) into the chemotherapy sensitive phases of the cell cycle. The stimulatory effect of

Granulocyte-Macrophage colony stimulatin

Granulocyte-Macrophage colony stimulating factor (GM-CSF) priming in the treatment of elderly patients with acute myelogenous leukemia

✍ Paul S. Frenette; Jane F. Desforges; David P. Schenkein; Arthur Rabson; Christop 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 783 KB

Randomized trial of 2 dosages of prophyl

Randomized trial of 2 dosages of prophylactic granulocyte–colony-stimulating factor after induction chemotherapy in pediatric acute myeloid leukemia

✍ Hiroto Inaba; Xueyuan Cao; Stanley Pounds; Ching-Hon Pui; Jeffrey E. Rubnitz; Ra 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB

Treatment of core-binding-factor in acut

Treatment of core-binding-factor in acute myelogenous leukemia with fludarabine, cytarabine, and granulocyte colony-stimulating factor results in improved event-free survival

✍ Gautam Borthakur; Hagop Kantarjian; Xuemei Wang; William K. Plunkett Jr; Varsha 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

Combination chemotherapy with low-dose c

Combination chemotherapy with low-dose cytarabine, homoharringtonine, and granulocyte colony-stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia

✍ Wang-Gang Zhang; Fang-Xia Wang; Yin-Xia Chen; Xin-Mei Cao; Ai-Li He; Jie Liu; Xi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 2 views

## Abstract As sensitization of leukemic cells with granulocyte colony‐stimulating factor (G‐csf) can enhance the cytotoxicity of chemotherapy in acute myeloid leukemia (AML), a pilot study was conducted in order to evaluate the effect of G‐csf priming combined with low‐dose chemotherapy in patient